Literature DB >> 24912426

Healed porcine incisions previously treated with a surgical incision management system: mechanical, histomorphometric, and gene expression properties.

Deepak V Kilpadi1, Chris Lessing, Kathleen Derrick.   

Abstract

BACKGROUND: Computer and bench models have shown previously that surgical incision management with negative pressure (SIM) immediately decreases lateral tissue tension and increases incisional apposition. Better apposition is known to improve healing. Thus, SIM was hypothesized to improve the quality of incisional healing. This study evaluated the impact that 5 days of SIM had on mechanical properties and associated changes in the histology/histomorphometry and gene expression of healed porcine incisions.
METHODS: One incision in each of the 4 pairs of contralateral, sutured, full-thickness incisions in each of 6 Yucatan swine were treated with either SIM (Prevena™ Incision Management System; n = 24 incisions/treatment group) or standard of care (SOC; sterile absorbent abdominal pads; n = 24/group) for 5 days, after which both groups received SOC for an additional 5 days. Biopsies for gene-expression analyses were collected on days 5 (n = 6 pairs/group), 20 (n = 6 pairs/group), and 40 (n = 12 pairs/group). On day 40, the animals were killed, after which healed incisions were harvested for mechanical testing (n = 12/group) and histologic/histomorphometric evaluation (n = 12/group).
RESULTS: Compared with SOC-treated incisions, SIM-treated incisions had significantly improved (p < 0.05) mechanical properties (strain energy density, peak strain) and a narrower scar/healed area in the deep dermis on day 40. Differences in gene expression between SOC- and SIM-treated specimens were observed primarily on day 5. The SIM-treated specimens had significantly fewer genes, which were differentially expressed and showed reduced upregulation of genes associated with inflammation, hypoxia, retardation of reepithelialization, impaired wound healing, and scarring.
CONCLUSION: Early application of SIM improved the quality of healed porcine incisions in terms of mechanical, histomorphometric, and gene-expression properties. NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24912426     DOI: 10.1007/s00266-014-0339-x

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  11 in total

1.  Closed-incision negative-pressure therapy decreases complications in ventral hernia repair with concurrent panniculectomy.

Authors:  S C Diaconu; C H L McNichols; L M Ngaage; Y Liang; E Ikheloa; J Bai; M P Grant; A J Nam; Y M Rasko
Journal:  Hernia       Date:  2018-12-17       Impact factor: 4.739

2.  Are high-risk patient and revision arthroplasty effective indications for closed-incisional negative-pressure wound therapy after total hip or knee arthroplasty? A systematic review and meta-analysis.

Authors:  Jun-Ho Kim; Dae-Hee Lee
Journal:  Int Wound J       Date:  2020-05-13       Impact factor: 3.315

3.  Gene expression of catabolic inflammatory cytokines peak before anabolic inflammatory cytokines after ACL injury in a preclinical model.

Authors:  Carla M Haslauer; Benedikt L Proffen; Victor M Johnson; Adele Hill; Martha M Murray
Journal:  J Inflamm (Lond)       Date:  2014-11-01       Impact factor: 4.981

Review 4.  Closed incision negative pressure therapy: international multidisciplinary consensus recommendations.

Authors:  Christian Willy; Animesh Agarwal; Charles A Andersen; Giorgio De Santis; Allen Gabriel; Onnen Grauhan; Omar M Guerra; Benjamin A Lipsky; Mahmoud B Malas; Lars L Mathiesen; Devinder P Singh; V Sreenath Reddy
Journal:  Int Wound J       Date:  2016-05-12       Impact factor: 3.315

5.  The application of close incisional negative pressure wound therapy in revision arthroplasty among asian patients: a comparative study.

Authors:  Ping Keung Chan; Wing Chiu Fung; Kar Hei Lam; Winnie Chan; Vincent Wai Kwan Chan; Henry Fu; Amy Cheung; Man Hong Cheung; Chun Hoi Yan; Kwong Yuen Chiu
Journal:  Arthroplasty       Date:  2021-11-03

6.  Simple and Efficient Pressure Ulcer Reconstruction via Primary Closure Combined with Closed-Incision Negative Pressure Wound Therapy (CiNPWT)-Experience of a Single Surgeon.

Authors:  Kuo-Feng Hsu; Li-Ting Kao; Pei-Yi Chu; Chun-Yu Chen; Yu-Yu Chou; Dun-Wei Huang; Ting-Hsuan Liu; Sheng-Lin Tsai; Chien-Wei Wu; Chih-Chun Hou; Chih-Hsin Wang; Niann-Tzyy Dai; Shyi-Gen Chen; Yuan-Sheng Tzeng
Journal:  J Pers Med       Date:  2022-01-29

7.  Effect of a new incision management system (PREVENA®) on wound healing after endophlebectomy of the common femoral vein: a case series.

Authors:  A Gombert; M E Barbati; C Wittens; J Grommes; H Jalaie
Journal:  J Med Case Rep       Date:  2016-05-27

8.  Assessment of Silver Levels in a Closed-Incision Negative Pressure Therapy Dressing: In Vitro and In Vivo Study.

Authors:  Prathamesh M Kharkar; Sandra N Osborne; Scout L Stern; Aaron Pleitner; K Mark Wiencek; Kristine M Kieswetter
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-07-22       Impact factor: 4.730

9.  Closed Incision Negative Pressure Wound Therapy After Resection of Large, Radiated, Soft Tissue Sarcomas.

Authors:  Timothy J Irwin; Dennis Orgill
Journal:  Cureus       Date:  2020-05-11

10.  Effect of closed incision negative pressure wound therapy on incidence rate of surgical site infection after stoma reversal: a pilot study.

Authors:  Maciej Borejsza-Wysocki; Adam Bobkiewicz; Wojciech Francuzik; Lukasz Krokowicz; Dominik Walczak; Jacek Szmeja; Tomasz Banasiewicz
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-05-25       Impact factor: 1.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.